<DOC>
	<DOC>NCT02651454</DOC>
	<brief_summary>The Purpose of this trial is to investigate the efficacy and safety of Daesiho-tang and Taeeumjowi-tang on Korean obese Women with metabolic syndrome Risk factors</brief_summary>
	<brief_title>A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Female aged 18 to 65 years Subject must included at least one or more of the following symptoms below BMI of 30 kg/㎡ or more; BMI between 25 and 29.9kg/㎡ with hypertension, taking medication or SBP ≥ 140mmHg or DBP ≥ 90mmHg at the screening visit BMI between 25 and 29.9kg/㎡ with noninsulindependent diabetes mellitus, taking medication or fasting blood glucose &gt; 126mg/dL at the screening visit BMI between 25 and 29.9kg/㎡ with hyperlipidemia, taking medication or total cholesterol ≥ 200mg/dL or Triglyceride ≥ 150mg/dL at screening visit Agreed to lowcalorie diet during the trial Written informed consent of the trial Endocrine diseases associated with weight gain, such as hypothyroidism, Cushing's syndrome, etc. Heart disease (heart failure, angina pectoris, myocardial infarction) Cholelithiasis Severe renal disability (SCr &gt; 2.0 mg/dL) Severe liver disability (2.5 fold of normal high range value on Alanine Aminotransferase [ALT], Aspartate Aminotransferase [AST], alkaline phosphatase) History of narrow angle glaucoma History of stroke or temporary ischemic cardioplegia History of eating disorder such as anorexia nervosa or bulimia nervosa, etc. Use of medication that can affect on weight within last 3 months (appetite suppressant, laxative, oral steroid, thyroid hormone, amphetamine, cyproheptadine, phenothiazine or medications can affect on absorption, metabolism, excretion) Use of CNS stimulant medication for weight loss Forbidden treatment (Insulin, hypoglycemic agent, antidepressant, antiserotonin agent, barbiturate, antipsychotic, medication concerns of abuse) history of weight loss surgery, such as bariatric surgery, etc. Subjects who are judged to be inappropriate for the clinical study by the researchers Women who were pregnant, lactating or have the chances of pregnancy who do not agree to proper contraception (birthcontrol pill, hormone implant, IUD, spermicide, condom, abstinence, etc.) Use of other investigational product within last 1 month 10 percent reduction in body weight over 6 months Decided to quit smoking over the last 3 months or have irregular smoking habits</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>metabolic syndrome</keyword>
	<keyword>Daesiho-tang</keyword>
	<keyword>Taeeumjowi-tang</keyword>
	<keyword>Korean medicine</keyword>
</DOC>